Comment: I have used the free PSA ratio (%fPSA) for years because it provides a reliable, cost-effective method to triage patients hovering in the PSA gray zone without immediately resorting to invasive procedures. Despite it being clear in the literature for decades, it is rare that I see it being used. The relatively recent availability […]
Comment: Although I am strong proponent of tests that don’t expose the patient to radiation or unnecessary contrast chemical, there are other types of risks. This study shows that this blood test fundamentally fails to detect early-stage disease, missing 86 out of the 121 cancers (71%) that surfaced during the 12-month study period. More alarmingly, […]
Comment: Medical surveillance fundamentally assumes that earlier detection equates to prolonged survival, making routine imaging an almost sacrosanct practice in oncology. Yet, this nationwide population-based study of non-Hodgkin lymphoma (NHL) survivors exposes an uncomfortable clinical reality: overzealous surveillance computed tomography (CT) drastically increases the risk of secondary primary malignancies (SPMs) without offering a proven overall […]
Comment: The traditional clinical focus on “detecting cancer early” ignores the underlying reality that “saving a life” in observational data is often a statistical artifact as screening has almost no impact on absolute survival. This 2017 population study from the Netherlands deconstructs a 23-year dataset to reveal a staggering truth: while breast cancer mortality (not […]
The Wonk Debate – Audio Critique & Clinical Commentary: 🙆♀️🩻Synthesized Clinical Bottom Line Updated 02-22-2026 The collective evidence—comprising meta-analyses of cohort studies and long-term randomized controlled trials (RCTs)—indicates that the profound survival benefits often attributed to mammography screening in observational data are largely artifacts of Healthy User Bias. While screening successfully identifies more early-stage disease, […]
Comment: A screening tool can only be as effective as the patient’s adherence to it. This NordICC study has been widely misrepresented as evidence of colonoscopy’s limited impact, yet that narrative relies on an intention-to-screen analysis that reflects an invitation to a procedure rather than the procedure itself. The NordICC results are a perfect example […]
Comment: The traditional clinical focus on “saving lives from breast cancer” ignores the underlying reality that “detecting a tumor earlier” does not equate to “lengthening that patient’s life.” This Cochrane review of 600,000 women published in 2013 deconstructs the evidence to reveal that while biased, suboptimally randomized trials suggest a benefit, the three adequately randomized […]
Comment: The traditional clinical focus on “detecting cancer early” ignores the underlying reality that “saving a life from breast cancer” in a cohort study does not equate to “lengthening that patient’s life” in a randomized trial. This comprehensive meta-analysis highlights a persistent survival paradox: while cohort studies suggest massive benefits, the randomized controlled trials (RCTs)—where […]
Comment: The traditional clinical focus on “detecting cancer early” ignores the historical trajectory of screening evidence, where every rigorous randomized trial has failed to demonstrate a statistically significant improvement in all-cause mortality. While this study reports that longer screening intervals are associated with “substantially worse OS,” we should recognize that this observational signal is notoriously […]
Comment: The traditional clinical focus and mantra of “early detection saves lives” ignores the underlying reality that “saving a life from breast cancer” does not equate to “lengthening that patient’s life.” This updated USPSTF recommendation highlights a persistent survival paradox: despite decades of technological advancement, screening mammography has never demonstrated a difference in all-cause mortality. […]
